Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (361-370 of 405) with videos related to

Pageof 41
Sort By:
American Heart Journal|December 12, 2018
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
European Journal of Heart Failure|July 6, 2012
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF studyG Michael Felker, Vic Hasselblad, W H Wilson Tang, et al.
European Heart Journal|August 28, 2012
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Ph Gabriel Steg, Stefan K James, et al.
Lancet (London, England)|September 2, 2025
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rossello, Eva Irene Bossano Prescott, Anna Meta Dyrvig Kristensen, et al.
Atherosclerosis|September 21, 2007
European guidelines on cardiovascular disease prevention in clinical practice: executive summaryIan Graham, Dan Atar, Knut Borch-Johnsen, et al.
European Heart Journal|May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled TrialA Michael Lincoff, Matthew Roe, Philip Aylward, et al.
Giornale Italiano Di Cardiologia (2006)|April 4, 2008
[European practice guidelines on prevention of cardiovascular diseases: executive summary]Ian Graham, Dan Atar, Knut Borch-Johnsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
Scientific Reports|December 21, 2023
Prognostic utility and characterization of left ventricular hypertrophy using global thicknessMagnus Lundin, Einar Heiberg, David Nordlund, et al.
Pageof 41

Showing results (361-370 of 405) with videos related to

Sort By:
Pageof 41
American Heart Journal|December 12, 2018
BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point studyJohn Munkhaugen, Vidar Ruddox, Sigrun Halvorsen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 9, 2019
Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular DiseasesGianluigi Savarese, Martin F Reiner, Alicia Uijl, et al.
European Journal of Heart Failure|July 6, 2012
Troponin I in acute decompensated heart failure: insights from the ASCEND-HF studyG Michael Felker, Vic Hasselblad, W H Wilson Tang, et al.
European Heart Journal|August 28, 2012
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Ph Gabriel Steg, Stefan K James, et al.
Lancet (London, England)|September 2, 2025
β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trialsXavier Rossello, Eva Irene Bossano Prescott, Anna Meta Dyrvig Kristensen, et al.
Atherosclerosis|September 21, 2007
European guidelines on cardiovascular disease prevention in clinical practice: executive summaryIan Graham, Dan Atar, Knut Borch-Johnsen, et al.
European Heart Journal|May 7, 2014
Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled TrialA Michael Lincoff, Matthew Roe, Philip Aylward, et al.
Giornale Italiano Di Cardiologia (2006)|April 4, 2008
[European practice guidelines on prevention of cardiovascular diseases: executive summary]Ian Graham, Dan Atar, Knut Borch-Johnsen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
Scientific Reports|December 21, 2023
Prognostic utility and characterization of left ventricular hypertrophy using global thicknessMagnus Lundin, Einar Heiberg, David Nordlund, et al.
Pageof 41